BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32862201)

  • 21. Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
    Phillips GS; Mengden-Koon S; Dhossche J; LeBoit PE; Goldstein AM; Lee I; Raffeld M; Papanicolau-Sengos A; Sargen MR; Chung J
    J Cutan Pathol; 2024 Mar; 51(3):198-204. PubMed ID: 38031352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
    Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
    Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the Spectrum of Microscopic and Cytogenetic Findings Associated With Spitz Tumors With 11p Gains.
    Lezcano CM; Yeh I; Eslamdoost N; Fang Y; LeBoit PE; McCalmont TH; Moy AP; Zhang Y; Busam KJ
    Am J Surg Pathol; 2021 Feb; 45(2):277-285. PubMed ID: 33428338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ROS1 pattern of immunostaining in 11 cases of spitzoid tumour: comparison with histopathological, fluorescence in-situ hybridisation and next-generation sequencing analysis.
    Cesinaro AM; Gallo G; Manfredini S; Maiorana A; Bettelli SR
    Histopathology; 2021 Dec; 79(6):966-974. PubMed ID: 34231248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, Morphological and Molecular Features of Spitz tumors.
    Donati M; Mansour B; Hagstrom M; Gerami P; Kazakov DV
    Cesk Patol; 2024; 60(1):35-48. PubMed ID: 38697826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis.
    Kastnerova L; Martinek P; Grossmann P; Steiner P; Vanecek T; Kyclova J; Ferak I; Zalud R; Slehobr O; Svajdler P; Sulc M; Bradamante M; Banik M; Hadravsky L; Sticova E; Hajkova V; Ptakova N; Michal M; Kazakov DV
    Am J Dermatopathol; 2020 Aug; 42(8):578-592. PubMed ID: 32701692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agminated presentation of fusion-driven melanocytic neoplasms.
    Fumero-Velázquez M; Hagstrom M; Dhillon S; Olivares S; Jennings LJ; Dittman D; Sukhanova M; Arva NC; Goldstein SD; Theos A; Pavlidakey P; Carr Z; Gerami P
    J Cutan Pathol; 2023 Oct; 50(10):913-921. PubMed ID: 37407520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
    Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
    J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRAF and NRAS mutations in spitzoid melanocytic lesions.
    Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
    Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology.
    Sunshine JC; Kim D; Zhang B; Compres EV; Khan AU; Busam KJ; Gerami P
    Am J Dermatopathol; 2020 Dec; 42(12):923-931. PubMed ID: 33289976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTRK3 kinase fusions in Spitz tumours.
    Yeh I; Tee MK; Botton T; Shain AH; Sparatta AJ; Gagnon A; Vemula SS; Garrido MC; Nakamaru K; Isoyama T; McCalmont TH; LeBoit PE; Bastian BC
    J Pathol; 2016 Nov; 240(3):282-290. PubMed ID: 27477320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.
    Fumero-Velázquez M; Hagstrom M; Dhillon S; Geraminejad T; Olivares S; Donati M; Nosek D; Waldenbäck P; Kazakov D; Sheffield BS; Tron VA; Gerami P
    Am J Surg Pathol; 2023 Dec; 47(12):1438-1448. PubMed ID: 37773074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Filigree-like Rete Ridges, Lobulated Nests, Rosette-like Structures, and Exaggerated Maturation Characterize Spitz Tumors With NTRK1 Fusion.
    Yeh I; Busam KJ; McCalmont TH; LeBoit PE; Pissaloux D; Alberti L; de la Fouchardière A; Bastian BC
    Am J Surg Pathol; 2019 Jun; 43(6):737-746. PubMed ID: 30844834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Update on Molecular Genetic Aberrations in Spitz Melanocytic Proliferations: Correlation with Morphological Features and Biological Behavior.
    Šekoranja D; Pižem J; Luzar B
    Acta Med Acad; 2021 Apr; 50(1):157-174. PubMed ID: 34075771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review.
    Salah HT; Yang RK; Roy-Chowdhuri S; Ross MI; Aung PP; Rothrock AT; Torres-Cabala CA; Curry JL; Prieto VG; Nagarajan P; Cho WC
    J Cutan Pathol; 2024 Jun; 51(6):407-414. PubMed ID: 38444194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphological and genetic aspects of Spitz tumors].
    Wiesner T; Kutzner H
    Pathologe; 2015 Feb; 36(1):37-43, 45. PubMed ID: 25613920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases.
    Mansour B; Vanecek T; Kastnerova L; Nosek D; Kazakov DV; Donati M
    Am J Dermatopathol; 2023 May; 45(5):306-310. PubMed ID: 36939120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphologic features in a series of 352 Spitz melanocytic proliferations help predict their oncogenic drivers.
    Kervarrec T; Pissaloux D; Tirode F; Samimi M; Jacquemus J; Castillo C; de la Fouchardière A
    Virchows Arch; 2022 Feb; 480(2):369-382. PubMed ID: 34761304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) Conundrum: PRKAR1A Inactivation Can Occur in Different Genetic Backgrounds (Common, Blue, and Spitz Subgroups) With Variation in Their Clinicopathologic Characteristics.
    de la Fouchardiere A; Tirode F; Castillo C; Buisson A; Boivin F; Macagno N; Pissaloux D
    Am J Surg Pathol; 2022 Aug; 46(8):1106-1115. PubMed ID: 35319526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.